anti-Hepatitis C Virus NS5a antibody product blog
Tags: Antibody; Monoclonal Antibody; Hepatitis C Virus NS5a; anti-Hepatitis C Virus NS5a antibody;
The Hepatitis C Virus NS5a n/a (Catalog #MBS530160) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s Hepatitis C Virus NS5a can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA), Immunohistochemistry (IHC), Western Blot (WB).IHC: 1:20
WB: 1:1,000. Researchers should empirically determine the suitability of the Hepatitis C Virus NS5a n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse monoclonal Hepatitis C Virus NS5a antibody.
Biological Significance: Hepatitis C is an infectious disease affecting the liver, caused by the hepatitis C virus (HCV). The infection is often asymptomatic, but once established, chronic infection can progress to scarring of the liver (fibrosis), and advanced scarring (cirrhosis) which is generally apparent after many years. In some cases, those with cirrhosis will go on to develop liver failure or other complications of cirrhosis, including liver cancer or life threatening esophageal varices and gastric varices. Cross-Reactivity: This antibody recognizes the HCV NS5a antigen
Biohazard Information: This product contains sodium azide as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing Hepatitis C Virus NS5a are readily searchable from our website. Different antibodies against the same target such as Hepatitis C Virus NS5a may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.